Lumen Biotech
LUMEN ·Demo IPO ·Healthcare
Fictional demonstration asset. Lumen Biotech is a made-up pre-IPO biotech used to illustrate low-confidence signals.
Radar Sweep
Radar Clear
No qualifying observations currently meet the selected threshold.
Blips in range
0Radar is scanning monitored evidence domains. No observations currently qualify.
Entity Vitals
Synthetic DemoMarket Activity
0 signals in the current 7-day window
Current
0
Baseline / 7d
0.16
Change
-100%
Activity relative to a 90-day rolling baseline. Unusual activity is not investment direction.
Convergence
No convergence detected
Radar currently sees activity for this entity, but not enough independently sourced intelligence domains have crossed the convergence threshold.
Market snapshot
Price
$18.00
Market cap
—
24h volume
—
1h change
—
24h change
—
7d change
—
Observed 1 month ago · 2026-09-02T21:16:02+00:00
Deterministic explanation
Fact-based- No qualifying momentum signal is currently present.
- The latest market observation is stale and may not reflect current conditions.
- No verified catalyst is available in the supplied evidence.
Market intelligence, not investment certainty. This score is not a forecast of future returns.
Deterministic Radar Score
Final score
45
Base score
56
Risk deduction
-11
Why this score
base 56 − risk penalty 11 = 45
- Social — · 5 pts
- Volume — · 7.5 pts
- Catalyst 78 · 15.6 pts
- Momentum — · 10 pts
- Fundamentals 50 · 7.5 pts
- Whale / On-chain — · 10 pts
Component scores
Social
0 signals · weight 10%
Insufficient evidence
Volume
0 signals · weight 15%
Insufficient evidence
Catalyst
1 signal · weight 20%
Momentum
0 signals · weight 20%
Insufficient evidence
Fundamentals
1 signal · weight 15%
Whale / On-chain
0 signals · weight 20%
Insufficient evidence
Risk radar
Liquidity unknown
mediumNo liquidity or volume observation is available for this asset.
Unverified catalyst
mediumA catalyst signal lacks a verifiable source or sufficient confidence.
Insufficient evidence
mediumToo few signal categories are available to form a confident view.
A high Radar Score never hides material risk. Risk flags remain visible at all times.
Evidence timeline
Pending FDA decision
A regulatory decision is pending; outcome unverified.
Early-stage pipeline
Limited public information about the product pipeline.
Radar Score 45
engine v1.0.0
Market observation recorded
Price 18
Counter-evidence
Why this matters
A recent verified signal (Pending FDA decision) entered the current window for Lumen Biotech.
Counter-evidence
- The most recent market observation is aging and may not reflect current conditions.
Limitations
- The signal is supported by limited evidence.
- Only one independently sourced intelligence domain currently qualifies for this entity.
What would strengthen
- A second independently sourced qualifying domain entering the same window.
- Additional reinforcing observations from verified sources.
What would weaken
- Activity returning toward its historical baseline as current observations age.
Evidence & sources
Synthetic demonstration
This asset uses synthetic demonstration data and is not a real market observation.
Provenance
Deterministic facts are stored separately from any AI interpretation. AI output never overwrites source observations. Unknown values remain unknown.
Last updated 1 month ago. Market intelligence, not investment certainty. Not investment advice.